China Medicine Corp.
CHME
Rank in Stocks
#32461
China Medicine Corporation produces and distributes prescription and over the... China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Share Price
$0.021
Last synced: 2026-11-12
Market Cap
$1.53M
Change (1 day)
0.00%
Change (1 year)
-47.50%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade China Medicine Corp. (CHME)
Category
Healthcare
Operating Margin for China Medicine Corp. (CHME)
Operating Margin as of November 2026 TTM: 0.00%
According to China Medicine Corp.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for China Medicine Corp. from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2009 | 18.94% | -7.02% |
| 2008 | 20.37% | 1.95% |
| 2007 | 19.98% | -22.50% |
| 2006 | 25.78% | 0.00% |
| 2005 | 0.00% | -100.00% |
| 2004 | 23.25% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | - |
US
|
|
| 31.60% | - |
SE
|
|
| 30.13% | - |
FR
|
|
| 29.76% | - |
HK
|
|
| 30.46% | - |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about China Medicine Corp.'s operating margin
What was China Medicine Corp.'s operating margin in 2025?
In 2025, China Medicine Corp.'s operating margin was 0.00%, compared with 18.94% in 2009.
How does China Medicine Corp.'s operating margin compare with similar companies?
China Medicine Corp.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.